Doubleblind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson’s disease patients - Stern, MB; Marek, KL; Friedman, J; Hauser, RA; LeWitt, PA; Tarsy, D; Olanow, CW (Mov Disord, 2004)